BMN 165

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN 165, covering 2018-09-10 to 2018-09-10. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 [Phase 3]